» Articles » PMID: 36829042

Comparison of Blocking Reagents for Antibody Microarray-based Immunoassays on Glass and Paper Membrane Substrates

Overview
Specialty Chemistry
Date 2023 Feb 24
PMID 36829042
Authors
Affiliations
Soon will be listed here.
Abstract

Background noise due to nonspecific binding of biomolecules on the assay substrates is one of the most common challenges that limits the sensitivity of microarray-based immunoassays. Background signal intensity usually increases when complex biological fluids are used because they have a combination of molecules and vesicles that can adsorb onto substrate surfaces. Blocking strategies coupled with surface chemistries can reduce such nonspecific binding and improve assay sensitivity. In this paper, we conducted a systematic optimization of blocking strategies on a variety of commonly used substrates for protein measurement in complex biofluids. Four blocking strategies (BSA, non-fat milk, PEG, and a protein-free solution) coupled with four surface chemistries (3-glycidoxypropyltrimethoxysilane (GPS), poly-L-lysine (PLL), aminoalkylsilane (AAS), and nitrocellulose (NC)) were studied for their effect on background, microspot, and net signal intensities. We have also explored the effect that these blocking strategies have when proteins in complex samples (plasma, serum, cell culture media, and EV lysate) are measured. Irregular spot morphology could affect signal extraction using automated software. We found that the microspots with the best morphology were the ones printed on GPS glass surfaces for all immunoassays. On NC membrane, the protein-based blocking strategies yielded the highest net fluorescent intensity with the antigen contained in PBS, plasma, serum, and serum-free cell culture media. Differently, with EV lysate samples, Pierce™ protein-free blocker yielded the best net signal intensity on both GPS and NC surfaces. The choice of blocking strategies highly depends on the substrate. Moreover, the findings discovered in this study are not limited to microarray-based immunoassays but can provide insights for other assay formats.

Citing Articles

Allergen Microarrays and New Physical Approaches to More Sensitive and Specific Detection of Allergen-Specific Antibodies.

Sokolov P, Evsegneeva I, Karaulov A, Sukhanova A, Nabiev I Biosensors (Basel). 2024; 14(7).

PMID: 39056629 PMC: 11275078. DOI: 10.3390/bios14070353.

References
1.
Summers A, Devadhasan J, Gu J, Montgomery D, Fischer B, Gates-Hollingsworth M . Optimization of an Antibody Microarray Printing Process Using a Designed Experiment. ACS Omega. 2022; 7(36):32262-32271. PMC: 9476517. DOI: 10.1021/acsomega.2c03595. View

2.
Quan X, Ding Y, Feng R, Zhu X, Zhang Q . Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray. Oncol Lett. 2018; 14(6):7360-7366. PMC: 5755243. DOI: 10.3892/ol.2017.7104. View

3.
Perlee L, Christiansen J, Dondero R, Grimwade B, Lejnine S, Mullenix M . Development and standardization of multiplexed antibody microarrays for use in quantitative proteomics. Proteome Sci. 2004; 2:9. PMC: 544832. DOI: 10.1186/1477-5956-2-9. View

4.
Kloppot P, Selle M, Kohler C, Stentzel S, Fuchs S, Liebscher V . Microarray-based identification of human antibodies against Staphylococcus aureus antigens. Proteomics Clin Appl. 2015; 9(11-12):1003-11. DOI: 10.1002/prca.201400123. View

5.
Berrade L, Garcia A, Camarero J . Protein microarrays: novel developments and applications. Pharm Res. 2010; 28(7):1480-99. PMC: 3137928. DOI: 10.1007/s11095-010-0325-1. View